EUA
OPTI SARS-CoV-2/ Influenza A/B RT-PCR Test (Version 1 and Version 2)
FDA Emergency Use Authorization · OPTI Medical Systems, Inc. · Apr 21, 2022
Key facts
| Product | OPTI SARS-CoV-2/ Influenza A/B RT-PCR Test (Version 1 and Version 2) |
|---|---|
| Company | OPTI Medical Systems, Inc. |
| Product type | Real-time RT-PCR, Multi-analyte, Multiple Targets |
| Date | Apr 21, 2022 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: